PI3K PROTAC overcomes the lapatinib resistance in PIK3CA-mutant HER2 positive breast cancer.
Zhang H, Zhang L, He Y, Jiang D, Sun J, Luo Q, Liang H, Wang T, Li F, Tang Y, Yang Z, Liu W, Rao Y, Chen C.
Zhang H, et al. Among authors: wang t.
Cancer Lett. 2024 Aug 28;598:217112. doi: 10.1016/j.canlet.2024.217112. Epub 2024 Jul 8.
Cancer Lett. 2024.
PMID: 38986734